Methodology and results of real-world cost-effectiveness of carfilzomib in combination with lenalidomide and dexamethasone in relapsed multiple myeloma using registry data
Titel:
Methodology and results of real-world cost-effectiveness of carfilzomib in combination with lenalidomide and dexamethasone in relapsed multiple myeloma using registry data
Auteur:
Campioni, M. Agirrezabal, I. Hajek, R. Minarik, J. Pour, L. Spicka, I. Gonzalez-McQuire, S. Jandova, P. Maisnar, V.